피임약 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 용도별, 형태별, 소재 유형별, 최종 사용자별(-2035년)

Contraceptives Market is anticipated to expand from $33.6 billion in 2024 to $56.4 billion by 2034, growing at a CAGR of approximately 5.1%. The Contraceptives Market encompasses products and methods used to prevent pregnancy, including hormonal pills, condoms, intrauterine devices, and sterilization procedures. This market is driven by increasing awareness of family planning, government initiatives, and technological advancements in contraceptive methods. Rising demand for long-acting reversible contraceptives and the growing emphasis on women's health are fueling innovations, ensuring both efficacy and safety.

The Contraceptives Market is experiencing robust growth, driven by increasing awareness and demand for family planning and reproductive health solutions. The oral contraceptives segment leads in performance, with combination pills and progestin-only pills being widely preferred due to their effectiveness and ease of use. The injectable contraceptives segment follows closely, reflecting rising popularity among women seeking long-term solutions without daily administration. The demand for contraceptive implants is also on the rise, offering prolonged protection and convenience. The male contraceptives segment, though currently underdeveloped, shows potential for growth as research and development efforts intensify. Non-hormonal contraceptives, such as copper IUDs, are gaining traction among individuals seeking hormone-free alternatives. Digital health applications for fertility tracking and contraceptive management are emerging as valuable tools, enhancing user engagement and adherence. Overall, the market is poised for expansion, with technological advancements and increasing investments in research and development driving innovation and accessibility.

The contraceptives market is characterized by a dynamic landscape of market share distribution, competitive pricing strategies, and a surge in innovative product launches. The sector is witnessing robust growth, fueled by increased consumer awareness and evolving societal attitudes towards family planning. Companies are intensifying their efforts in research and development to introduce advanced contraceptive solutions, catering to diverse consumer needs. Pricing strategies remain competitive, with key players leveraging economies of scale to offer cost-effective options. The market is further buoyed by strategic collaborations and partnerships aimed at expanding product portfolios and enhancing market penetration. Competition within the contraceptives market is intense, with major players striving to differentiate through innovation and brand positioning. Regulatory frameworks across various regions significantly influence market dynamics, with stringent guidelines ensuring product safety and efficacy. The landscape is shaped by a few dominant players, yet new entrants are making notable inroads. Regulatory bodies in North America and Europe continue to set stringent standards, impacting product approval timelines and market entry strategies. The market is poised for sustained growth, driven by technological advancements and increasing demand for personalized contraceptive options.

Geographical Overview:

The contraceptives market is witnessing varied growth dynamics across different regions, with emerging opportunities in several countries. North America remains a dominant player, driven by increased awareness and the availability of advanced contraceptive methods. The region's robust healthcare infrastructure supports market expansion. Europe also demonstrates strong growth, buoyed by government initiatives promoting family planning and reproductive health. Asia Pacific is a burgeoning market, with rapid urbanization and rising disposable incomes contributing to increased demand for contraceptives. Countries like India and China are at the forefront, with significant investments in healthcare and education. Latin America is emerging as a promising market, with Brazil and Mexico leading due to progressive health policies and improved access to contraceptives. In the Middle East & Africa, there is a growing recognition of the importance of reproductive health, with countries like South Africa and Nigeria showing potential. Efforts to improve healthcare access and education are key drivers in these regions.

Global tariffs and geopolitical tensions are significantly influencing the contraceptives market, particularly in East Asia. Japan and South Korea are navigating these challenges by diversifying suppliers and investing in domestic pharmaceutical innovation to mitigate tariff impacts. China is focusing on self-reliance, enhancing its manufacturing capabilities to reduce dependency on international imports. Taiwan, a key player in pharmaceutical components, faces geopolitical risks that could disrupt supply chains. The global contraceptives market is experiencing steady growth, driven by increasing awareness and demand for reproductive health products. By 2035, the market is anticipated to evolve with advanced product offerings and improved accessibility. Middle East conflicts contribute to volatile energy prices, indirectly affecting manufacturing and distribution costs across the pharmaceutical industry, including contraceptives.

Key Trends and Drivers:

The contraceptives market is experiencing robust growth fueled by rising awareness and demand for family planning and reproductive health. Increasing government initiatives and educational campaigns are promoting the use of contraceptives, enhancing accessibility and awareness among diverse populations. The emergence of innovative contraceptive technologies, including long-acting reversible contraceptives, is catering to the evolving preferences of consumers seeking convenience and efficacy. Moreover, the growing emphasis on women's health and empowerment is driving the adoption of contraceptives, as women seek greater control over their reproductive choices. The market is witnessing a shift towards non-hormonal contraceptive options, reflecting consumer demand for safer and more natural alternatives. In addition, the expansion of telemedicine and digital health platforms is facilitating easier access to contraceptive products and consultations, particularly in remote areas. Opportunities abound in emerging economies where increasing urbanization and changing lifestyles are driving demand for contraceptive solutions. Companies that focus on affordability and accessibility are well-positioned to capture significant market share. Furthermore, partnerships with healthcare providers and NGOs can enhance distribution networks and outreach efforts, ensuring broader access to contraceptive options. The market's trajectory is poised for continuous growth, supported by technological advancements and a global focus on reproductive health and rights.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Form
• 2.7 Key Market Highlights by Material Type
• 2.8 Key Market Highlights by End User

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Hormonal
  • 4.1.2 Barrier
  • 4.1.3 Intrauterine
  • 4.1.4 Sterilization
  • 4.1.5 Natural
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Condoms
  • 4.2.2 Oral Contraceptive Pills
  • 4.2.3 Injectables
  • 4.2.4 Implants
  • 4.2.5 Intrauterine Devices (IUDs)
  • 4.2.6 Emergency Contraceptives
  • 4.2.7 Vaginal Rings
  • 4.2.8 Patches
  • 4.2.9 Spermicides
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Family Planning Services
  • 4.3.2 Counseling Services
  • 4.3.3 Educational Services
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Long-acting Reversible Contraceptives (LARC)
  • 4.4.2 Short-acting Hormonal Methods
  • 4.4.3 Permanent Methods
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Preventive
  • 4.5.2 Therapeutic
• 4.6 Market Size & Forecast by Form (2020-2035)
  • 4.6.1 Oral
  • 4.6.2 Injectable
  • 4.6.3 Topical
  • 4.6.4 Implantable
• 4.7 Market Size & Forecast by Material Type (2020-2035)
  • 4.7.1 Latex
  • 4.7.2 Non-Latex
  • 4.7.3 Polyurethane
• 4.8 Market Size & Forecast by End User (2020-2035)
  • 4.8.1 Hospitals
  • 4.8.2 Clinics
  • 4.8.3 Homecare

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Form
    • 5.2.1.7 Material Type
    • 5.2.1.8 End User
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Form
    • 5.2.2.7 Material Type
    • 5.2.2.8 End User
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Form
    • 5.2.3.7 Material Type
    • 5.2.3.8 End User
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Form
    • 5.3.1.7 Material Type
    • 5.3.1.8 End User
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Form
    • 5.3.2.7 Material Type
    • 5.3.2.8 End User
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Form
    • 5.3.3.7 Material Type
    • 5.3.3.8 End User
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Form
    • 5.4.1.7 Material Type
    • 5.4.1.8 End User
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Form
    • 5.4.2.7 Material Type
    • 5.4.2.8 End User
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Form
    • 5.4.3.7 Material Type
    • 5.4.3.8 End User
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Form
    • 5.4.4.7 Material Type
    • 5.4.4.8 End User
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Form
    • 5.4.5.7 Material Type
    • 5.4.5.8 End User
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Form
    • 5.4.6.7 Material Type
    • 5.4.6.8 End User
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Form
    • 5.4.7.7 Material Type
    • 5.4.7.8 End User
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Form
    • 5.5.1.7 Material Type
    • 5.5.1.8 End User
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Form
    • 5.5.2.7 Material Type
    • 5.5.2.8 End User
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Form
    • 5.5.3.7 Material Type
    • 5.5.3.8 End User
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Form
    • 5.5.4.7 Material Type
    • 5.5.4.8 End User
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Form
    • 5.5.5.7 Material Type
    • 5.5.5.8 End User
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Form
    • 5.5.6.7 Material Type
    • 5.5.6.8 End User
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Form
    • 5.6.1.7 Material Type
    • 5.6.1.8 End User
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Form
    • 5.6.2.7 Material Type
    • 5.6.2.8 End User
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Form
    • 5.6.3.7 Material Type
    • 5.6.3.8 End User
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Form
    • 5.6.4.7 Material Type
    • 5.6.4.8 End User
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Form
    • 5.6.5.7 Material Type
    • 5.6.5.8 End User

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Reckitt Benckiser Group
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Church & Dwight
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Mayer Laboratories
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Mankind Pharma
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Cupid Limited
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Fuji Latex Co Ltd
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 HLL Lifecare Limited
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Veru Inc
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Okamoto Industries
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Ansell Limited
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Sagami Rubber Industries
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Karex Berhad
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Thai Nippon Rubber Industry
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Bio Film Inc
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Shanghai Dahua Medical Apparatus
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Sir Richard's Condom Company
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 RFSU AB
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Caya
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Bexen Medical
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Lelo
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us